Artificial intelligence against hair loss?
AI helps researchers design microneedle patches that restore hair in balding mice
Computer-generated image
Most people with substantial hair loss have the condition androgenic alopecia, also called male- or female-pattern baldness. In this condition, hair follicles can be damaged by androgens, inflammation or an overabundance of reactive oxygen species, such as oxygen free radicals. When the levels of oxygen free radicals are too high, they can overwhelm the body’s antioxidant enzymes that typically keep them in check. Superoxide dismutase (SOD) is one of these enzymes, and researchers have recently created SOD mimics called “nanozymes.” But so far, those that have been reported aren’t very good at removing oxygen free radicals. So, Lina Wang, Zhiling Zhu and colleagues wanted to see whether machine learning, a form of AI, could help them design a better nanozyme for treating hair loss.
The researchers chose transition-metal thiophosphate compounds as potential nanozyme candidates. They tested machine-learning models with 91 different transition-metal, phosphate and sulfate combinations, and the techniques predicted that MnPS3 would have the most powerful SOD-like ability. Next, MnPS3 nanosheets were synthesized through chemical vapor transport of manganese, red phosphorus and sulfur powders. In initial tests with human skin fibroblast cells, the nanosheets significantly reduced the levels of reactive oxygen species without causing harm.
Based on these results, the team prepared MnPS3 microneedle patches and treated androgenic alopecia-affected mouse models with them. Within 13 days, the animals regenerated thicker hair strands that more densely covered their previously bald backsides than mice treated with testosterone or minoxidil. The researchers say that their study both produced a nanozyme treatment for regenerating hair, and indicated the potential for computer-based methods for use in the design of future nanozyme therapeutics.
Original publication
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.